Skip to main content
Premium Trial:

Request an Annual Quote

Powertech, Pressure BioSciences Ink Chinese Distribution Agreement

NEW YORK (GenomeWeb) – Pressure BioSciences today announced an exclusive agreement with Powertech Technology for the distribution of Pressure Bio's pressure cycling technology in China.

The deal is for three years. Pressure Bio did not disclose additional details about the agreement.

Based in Xiamen, China, Powertech distributes analytical instruments to the biotechnology, pharmaceutical, commercial testing laboratory, and other markets in China.

Pressure Bio Vice President of Marketing and Sales Nathan Lawrence said in a statement that the company believes China to be the biggest market for PCT products outside of the US. Along with use of PCT by China's proteomics, genomics, and lipidomics researchers, Powertech's customer base includes agricultural, food safety, and environmental laboratories, "the types of facilities we believe will make up the majority of the next wave of potential customers for our PCT-based products," said Lawrence.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.